These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33417955)

  • 1. Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats.
    Goto M; Azuma K; Arima H; Kaneko S; Higashi T; Motoyama K; Michihara A; Shimizu T; Kadowaki D; Maruyama T; Otagiri M; Iohara D; Hirayama F; Anraku M
    Life Sci; 2021 Mar; 268():118991. PubMed ID: 33417955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota.
    Goto M; Iohara D; Michihara A; Ifuku S; Azuma K; Kadowaki D; Maruyama T; Otagiri M; Hirayama F; Anraku M
    Int J Biol Macromol; 2020 Dec; 164():659-666. PubMed ID: 32698063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.
    Moriya T; Kitamori K; Naito H; Yanagiba Y; Ito Y; Yamagishi N; Tamada H; Jia X; Tsuchikura S; Ikeda K; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 Nov; 17(6):444-56. PubMed ID: 22407906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats.
    Kakimoto M; Fujii M; Sato I; Honma K; Nakayama H; Kirihara S; Fukuoka T; Ran S; Hirohata S; Kitamori K; Yamamoto S; Watanabe S
    J Appl Biomed; 2023 Jun; 21(2):80-90. PubMed ID: 37376883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses.
    Yamamoto S; Honma K; Fujii M; Kakimoto M; Kirihara S; Nakayama H; Kitamori K; Sato I; Hirohata S; Watanabe S
    Ann Anat; 2023 Aug; 249():152104. PubMed ID: 37209870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.
    Watanabe S; Kumazaki S; Kusunoki K; Inoue T; Maeda Y; Usui S; Shinohata R; Ohtsuki T; Hirohata S; Kusachi S; Kitamori K; Mori M; Yamori Y; Oka H
    J Atheroscler Thromb; 2018 May; 25(5):439-453. PubMed ID: 29162773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.
    Watanabe S; Kumazaki S; Yamamoto S; Sato I; Kitamori K; Mori M; Yamori Y; Hirohata S
    Int J Exp Pathol; 2018 Dec; 99(6):282-294. PubMed ID: 30680827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.
    Kitamori K; Naito H; Tamada H; Kobayashi M; Miyazawa D; Yasui Y; Sonoda K; Tsuchikura S; Yasui N; Ikeda K; Moriya T; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 May; 17(3):173-82. PubMed ID: 21853259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.
    Sato I; Yamamoto S; Kakimoto M; Fujii M; Honma K; Kumazaki S; Matsui M; Nakayama H; Kirihara S; Ran S; Usui S; Shinohata R; Kitamori K; Hirohata S; Watanabe S
    Pharmacol Rep; 2022 Aug; 74(4):669-683. PubMed ID: 35819592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid attenuates high-fat diet-induced steatohepatitis
    Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
    World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1)
    Sun T; Zhang B; Ru QJ; Chen XM; Lv BD
    Pharm Biol; 2021 Dec; 59(1):723-731. PubMed ID: 34139927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study.
    Sonoda K; Kono Y; Kitamori K; Ohtake K; Shiba S; Kasono K; Kobayashi J
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.
    Zhao ZH; Xin FZ; Zhou D; Xue YQ; Liu XL; Yang RX; Pan Q; Fan JG
    World J Gastroenterol; 2019 May; 25(20):2450-2462. PubMed ID: 31171889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis.
    Kabel AM; Abd Elmaaboud MA; Albarraq AA
    Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():1-9. PubMed ID: 25541279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota.
    Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
    Int Immunopharmacol; 2021 Oct; 99():108065. PubMed ID: 34426119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.
    Naito H; Jia X; Yetti H; Yanagiba Y; Tamada H; Kitamori K; Hayashi Y; Wang D; Kato M; Ishii A; Nakajima T
    Environ Health Prev Med; 2016 Sep; 21(5):368-381. PubMed ID: 27209494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.
    Chen D; Xiong J; Chen G; Zhang Z; Liu Y; Xu J; Xu H
    In Vivo; 2023; 37(5):2105-2127. PubMed ID: 37652508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.